The first available therapeutically equivalent version of Copaxone, Brabio is now available to prescribe for the treatment of relapsing forms of MS.
Brabio is available in the same 20mg/ml and 40mg/ml prefilled syringe presentations as Copaxone, for once-daily and three-times weekly administration, respectively.
Glatiramer acetate is a synthetic protein that mimics myelin basic protein, a component of the myelin that insulates nerve fibres in the brain and spinal cord. It seems to block myelin-damaging T-cells through a mechanism that is not completely understood.
Early and ongoing treatment with disease-modifying therapies such as glatiramer is thought to be the best way to reduce future disease activity for people with relapsing forms of MS.